Sanofi Pasteur, the vaccines division of French drug maker Sanofi, has unveiled an injectable inactivated polio vaccine (IPV) named ShanIPV that will be delivered through UNICEF in India. The vaccine was launched by the Telangana Cheif Minister K Chandrasekhar Rao in Hyderabad on Friday. Sanofi Pasteur’s affiliated Shantha Biotechnics Pvt. Ltd. will manufacture the ShanIPV in Hyderabad.
At the launching event, the company revealed that it will manufacture 2.3 million doses of ShanIPV in 2015 while 9 million units will be supplied to Unicef in 2016 for India’s need. In addition, the company aims to manufacture more than 10 million doses of ShanIPV in 2016 and the numbers can further go up as per the demands.
ShanIPV will be given at the age of 14 weeks for babies and will provide protection against three strains of virus. The new IPV will work along with already present IPV in the Indian market. Sanofi produces similar IPV doses in India under the brand name Imovax Polio. While commenting the price of the new IPV, the company official said the ShanIPV will cost around INR 54-55 per dose similar to the prices of Sanofi’s Imovax Polio vaccines.
“Today, we are proud to further strengthen our commitment towards disease prevention and support the Indian Government’s universal immunisation programme, including polio eradication. With the introduction of IPV in the immunisation schedule, our company is playing a key role in achieving the goal of a polio-free world,” said Shailesh Ayyangar, managing director- India and vice president-South Asia,of Sanofi.
First phase of immunisation will commence on Dec 1 in six states including Assam, Bihar, Uttar Pradesh, Gujarat, Madhya Pradesh and Punjab. Moreover, India became polio-free nation on 27 March 2014, however, the immunisation programme can not stop since, the neighbouring two countries of India –Pakistan and Afghanistan are polio-endemic nations.